Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PROXY Laboratories is a Netherlands-based bio/pharma services company focused on quality control testing, analytical method development and validation, stability studies, EU import analysis and batch release for pharmaceutical and biopharmaceutical products. The business also offers aseptic small-scale compounding and fill-finish manufacturing of sterile clinical trial materials, along with labeling, packaging, storage, distribution, and QP batch certification services. Founded in 2001 in Leiden, the company expanded through acquisitions and mergers before becoming part of Sinensis Life Sciences in 2012. Sinensis was acquired by Eurofins in January 2016, and the business subsequently operated as Eurofins PROXY Laboratories. In 2026, the legal entity name changed to Eurofins BioPharma Product Testing Leiden B.V., making PROXY Laboratories effectively a legacy and brand-transition name rather than a standalone independent company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PROXY Laboratories.